company

University of Manchester

as of 2026-07-01
Monitor thisAsk about this
at a glance
23 trials sponsored · 33 assets in the graph
Synthesized from structured facts only — each point cited above.

Financials

SEC EDGAR XBRL · latest period per metric
No financials loaded for this company (may be non-US-listed — recorded as a gap, not faked).

Pipeline

33 assets
AmisulprideClozapineMinocyclineOlanzapineRisperidoneA-iMAPSAffect Dysregulation interventionAvatar therapyCitalopramCognitive AppRoaches to coMbatting Suicidality (CARMS)Cognitive RemediationCognitive behavioural therapy (CBT)Culturally Adapted Cognitive behavior therapyCulturally-adapted cognitive-behavioural therapyDisturbed Relationships interventionFamily interventionGlycopyrrolateHigh dose AUT00206 2000 mgHyoscineJumping to conclusions interventionKetamineLink work interventionLow dose AUT00206 800mgMethod of LevelsMethod of Levels therapyNegative Self Concept interventionPsychosocial interventionSelf Directed Positive Parenting ProgramSelf-esteem interventionSelf-stigma interventionSocial cognition trainingTriple P Positive Parenting Programmepsychological therapy Method of Levels (MOL)

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
asset
Amisulpride
small molecule
drug
Clozapine
small molecule
drug
Minocycline
small molecule
drug
Olanzapine
small molecule
drug
Risperidone
small molecule
drug
A-iMAPS
BEHAVIORAL
drug
Affect Dysregulation intervention
BEHAVIORAL
drug
Avatar therapy
BEHAVIORAL
drug